Advertisement

For Every Little Problem, a Pharmaceutical Answer

Share

Let’s be honest: If you or I were as dependent on psychotropic drugs as this nation is, we’d be in rehab.

The Food and Drug Administration has finally proposed warning labels on antidepressants because they may promote suicidal tendencies -- and we should be thankful. But isn’t this just a small patch on a nasty wound?

In the early 1960s, tranquilizers were introduced into the U.S. and were marketed so heavily that, by 1968, Valium became the most prescribed drug in the country. And the party hasn’t stopped since. Didn’t doctors know at the time that the drug was being abused and overprescribed, that it was addictive? Of course. Did they continue to prescribe it? Of course. Did the manufacturer continue to provide it? Need you ask?

Advertisement

Our society once had an old common-sense virtue that psychotropic drugs should be used as a last resort. Why? Because these drugs, while useful in extreme circumstances, can have nasty effects like addiction, rages, altered judgment, divorce and, yes, suicidal impulses.

Yet we have become so muddle-headed by constant marketing to take these drugs for every emotional malady that we now live in a ridiculous world where we have signs that say “This is a Drug-Free Zone” on the front of a school that is handing out psychotropics to the children for depression, hyperactivity, anxiety, etc.

Psychiatric drugs have become a first resort. That is the real nightmare the FDA should confront. Doctors no longer look for causes of depression, such as thyroid problems, lack of exercise, a bad diet, a guilty conscience, medical problems, allergies -- the likely culprits could be many. By using drugs to treat the symptoms, they not only expose patients to the effects of the drugs but they let the real causes go untreated.

And by encouraging drug use to get over ordinary life experiences, such as a death in the family or teenage shyness, physicians numb the pain that so often contributes to maturity and emotional growth.

The FDA needs to step up to the plate: psychiatric drugs as a last resort.

*

Dan Stradford is the president and founder of Safe Harbor, a nonprofit organization for non-drug mental health education.

Advertisement